The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antidepressants-Global Market Insights and Sales Trends 2024
Synopsis
The global Antidepressants market size is expected to reach US$ 18090 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antidepressants in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Antidepressants market. Tricyclic Antidepressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Serotonin Reuptake Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidepressants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidepressants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidepressants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidepressants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidepressants covered in this report include H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson and Merck, etc.
The global Antidepressants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi
Global Antidepressants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidepressants market, Segment by Type:
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents
Global Antidepressants market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Antidepressants market size is expected to reach US$ 18090 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antidepressants in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Antidepressants market. Tricyclic Antidepressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Serotonin Reuptake Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidepressants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidepressants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidepressants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidepressants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidepressants covered in this report include H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson and Merck, etc.
The global Antidepressants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi
Global Antidepressants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidepressants market, Segment by Type:
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents
Global Antidepressants market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antidepressants Market Overview
1.1 Antidepressants Product Overview
1.2 Antidepressants Market Segment by Type
1.2.1 Tricyclic Antidepressants
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Selective Norepinephrine Reuptake Inhibitors
1.2.4 Monoamine Oxidase Inhibitors
1.2.5 Benzodiazepines
1.2.6 Antipsychotics
1.2.7 Novel Agents
1.3 Global Antidepressants Market Size by Type
1.3.1 Global Antidepressants Market Size Overview by Type (2018-2029)
1.3.2 Global Antidepressants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antidepressants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidepressants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antidepressants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antidepressants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antidepressants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antidepressants Sales Breakdown by Type (2018-2023)
2 Global Antidepressants Market Competition by Company
2.1 Global Top Players by Antidepressants Sales (2018-2023)
2.2 Global Top Players by Antidepressants Revenue (2018-2023)
2.3 Global Top Players by Antidepressants Price (2018-2023)
2.4 Global Top Manufacturers Antidepressants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidepressants Market Competitive Situation and Trends
2.5.1 Antidepressants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidepressants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidepressants as of 2022)
2.7 Date of Key Manufacturers Enter into Antidepressants Market
2.8 Key Manufacturers Antidepressants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidepressants Status and Outlook by Region
3.1 Global Antidepressants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antidepressants Historic Market Size by Region
3.2.1 Global Antidepressants Sales in Volume by Region (2018-2023)
3.2.2 Global Antidepressants Sales in Value by Region (2018-2023)
3.2.3 Global Antidepressants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antidepressants Forecasted Market Size by Region
3.3.1 Global Antidepressants Sales in Volume by Region (2024-2029)
3.3.2 Global Antidepressants Sales in Value by Region (2024-2029)
3.3.3 Global Antidepressants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antidepressants by Application
4.1 Antidepressants Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Antidepressants Market Size by Application
4.2.1 Global Antidepressants Market Size Overview by Application (2018-2029)
4.2.2 Global Antidepressants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antidepressants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidepressants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antidepressants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antidepressants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antidepressants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antidepressants Sales Breakdown by Application (2018-2023)
5 North America Antidepressants by Country
5.1 North America Antidepressants Historic Market Size by Country
5.1.1 North America Antidepressants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antidepressants Sales in Volume by Country (2018-2023)
5.1.3 North America Antidepressants Sales in Value by Country (2018-2023)
5.2 North America Antidepressants Forecasted Market Size by Country
5.2.1 North America Antidepressants Sales in Volume by Country (2024-2029)
5.2.2 North America Antidepressants Sales in Value by Country (2024-2029)
6 Europe Antidepressants by Country
6.1 Europe Antidepressants Historic Market Size by Country
6.1.1 Europe Antidepressants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antidepressants Sales in Volume by Country (2018-2023)
6.1.3 Europe Antidepressants Sales in Value by Country (2018-2023)
6.2 Europe Antidepressants Forecasted Market Size by Country
6.2.1 Europe Antidepressants Sales in Volume by Country (2024-2029)
6.2.2 Europe Antidepressants Sales in Value by Country (2024-2029)
7 Asia-Pacific Antidepressants by Region
7.1 Asia-Pacific Antidepressants Historic Market Size by Region
7.1.1 Asia-Pacific Antidepressants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antidepressants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antidepressants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antidepressants Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidepressants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antidepressants Sales in Value by Region (2024-2029)
8 Latin America Antidepressants by Country
8.1 Latin America Antidepressants Historic Market Size by Country
8.1.1 Latin America Antidepressants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antidepressants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antidepressants Sales in Value by Country (2018-2023)
8.2 Latin America Antidepressants Forecasted Market Size by Country
8.2.1 Latin America Antidepressants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antidepressants Sales in Value by Country (2024-2029)
9 Middle East and Africa Antidepressants by Country
9.1 Middle East and Africa Antidepressants Historic Market Size by Country
9.1.1 Middle East and Africa Antidepressants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antidepressants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antidepressants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antidepressants Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidepressants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antidepressants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 H Lundbeck
10.1.1 H Lundbeck Company Information
10.1.2 H Lundbeck Introduction and Business Overview
10.1.3 H Lundbeck Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 H Lundbeck Antidepressants Products Offered
10.1.5 H Lundbeck Recent Development
10.2 Astrazeneca
10.2.1 Astrazeneca Company Information
10.2.2 Astrazeneca Introduction and Business Overview
10.2.3 Astrazeneca Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Astrazeneca Antidepressants Products Offered
10.2.5 Astrazeneca Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly and Company Antidepressants Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Sun Pharmaceuticals
10.4.1 Sun Pharmaceuticals Company Information
10.4.2 Sun Pharmaceuticals Introduction and Business Overview
10.4.3 Sun Pharmaceuticals Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharmaceuticals Antidepressants Products Offered
10.4.5 Sun Pharmaceuticals Recent Development
10.5 Pfizer Inc.
10.5.1 Pfizer Inc. Company Information
10.5.2 Pfizer Inc. Introduction and Business Overview
10.5.3 Pfizer Inc. Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Inc. Antidepressants Products Offered
10.5.5 Pfizer Inc. Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Antidepressants Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Bristol-Myers Squibb Company
10.7.1 Bristol-Myers Squibb Company Company Information
10.7.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bristol-Myers Squibb Company Antidepressants Products Offered
10.7.5 Bristol-Myers Squibb Company Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Antidepressants Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck Antidepressants Products Offered
10.9.5 Merck Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Antidepressants Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sanofi Antidepressants Products Offered
10.10.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidepressants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidepressants Industrial Chain Analysis
11.4 Antidepressants Market Dynamics
11.4.1 Antidepressants Industry Trends
11.4.2 Antidepressants Market Drivers
11.4.3 Antidepressants Market Challenges
11.4.4 Antidepressants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidepressants Distributors
12.3 Antidepressants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
